Evidence map›Paper›PMID 31323264›Full record

ArticleToxicology and applied pharmacology2019

Determination of chemical-disease risk values to prioritize connections between environmental factors, genetic variants, and human diseases.

Marissa B Kosnik, David M Reif

Abstract read
In one paragraph

Article in Toxicology and applied pharmacology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Marissa B KosnikToxicology Program, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7617, United States of America. Electronic address: mbkosnik@ncsu.edu.
David M ReifToxicology Program, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Bioinformatics Research Center, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Department of Biological Sciences, North Carolina State University, Raleigh, NC 27695-7617, United States of America; Center for Human Health and the Environment, North Carolina State University, Raleigh, NC 27695-7617, United States of America. Electronic address: dmreif@ncsu.edu.

Funding

Translational Research Support CoreP30ES025128 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Andrew R. Binder · 2015 to 2026
$18.3M
TRAINING IN BIOCHEMICAL AND ENVIRONMENTAL TOXICOLOGYT32ES007046 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI Seth William Kullman · 1985 to 2026
$5.1M
Genetic Etiology of Cancer Drug ResponseR01CA161608 · NCI · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI WILTSHIRE, TIM, WRIGHT, FRED A. · 2012 to 2021
$4.0M
Gene-Environment Interactions Causing Differential Susceptibility to Chemical Exposure in High-Throughput ScreeningR56ES030007 · NIEHS · NORTH CAROLINA STATE UNIVERSITY RALEIGH · PI REIF, DAVID M · 2019 to 2019
$225k
EPA R835802NCI NIH HHS R01 CA161608NIEHS NIH HHS P30 ES025128NIEHS NIH HHS R56 ES030007NIEHS NIH HHS T32 ES007046
6 · The paper itself

Abstract

Traditional methods for chemical risk assessment are too time-consuming and resource-intensive to characterize either the diversity of chemicals to which humans are exposed or how that diversity may manifest in population susceptibility differences. The advent of novel toxicological data sources and their integration with bioinformatic databases affords opportunities for modern approaches that consider gene-environment (GxE) interactions in population risk assessment. Here, we present an approach that systematically links multiple data sources to relate chemical risk values to diseases and gene-disease variants. These data sources include high-throughput screening (HTS) results from Tox21/ToxCast, chemical-disease relationships from the Comparative Toxicogenomics Database (CTD), hazard data from resources like the Integrated Risk Information System, exposure data from the ExpoCast initiative, and gene-variant-disease information from the DisGeNET database. We use these integrated data to identify variants implicated in chemical-disease enrichments and develop a new value that estimates the risk of these associations toward differential population responses. Finally, we use this value to prioritize chemical-disease associations by exploring the genomic distribution of variants implicated in high-risk diseases. We offer this modular approach, termed DisQGOS (Disease Quotient Genetic Overview Score), for relating overall chemical-disease risk to potential for population variable responses, as a complement to methods aiming to modernize aspects of risk assessment.

Indexed as

Gene-Environment InteractionGenetic VariationRisk AssessmentAnimalsDatabases, FactualDatasets as TopicEnvironmental ExposureGenetic Predisposition to DiseaseHigh-Throughput Screening AssaysHumansInformation Storage and RetrievalToxicologyData integrationGene-environment interactionsNew approach methodologiesRisk assessment

Identifiers

PMID31323264
PMCPMC6708494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.